Abstract:We read with great interest the study by Fang and colleagues [[1]Fang Z.L. Sabin C.A. Dong B.Q. Wei S.C. Chen Q.Y. Fang K.X. et al.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.J Hepatol. 2009; 50: 273-280Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar] that evaluated the association of HBV core promoter double mutations (A1762T and G1764A) with viral loads between HBeAg positive and anti-HBe positive individuals. In their study, the authors concluded that BCP double mutations are associated with lower viral loads in HBeAg positive individuals, but have no effect on the viral loads of anti-HBe positive individuals. Our concerns regarding this study and its conclusions are outlined as follows: It is well known that treatment with an antiviral therapy, such as lamivudine therapy, can give rise to HBV mutations, including core promoter mutations [[2]Chen C.H. Lee C.M. Lu S.N. Changchien C.S. Wang J.C. Wang J.H. et al.Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.J Hepatol. 2006; 44: 76-82Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar] or biochemical and virological breakthrough [[3]Yuen M.F. Sablon E. Hui C.K. Yuan H.J. Decraemer H. Lai C.L. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.Hepatology. 2001; 34: 785-791Crossref PubMed Scopus (357) Google Scholar]. Moreover, antiviral therapies, including nucleotide analogy, are widely used for the treatment of hepatitis B in urban and rural areas of China. Although the authors have mentioned that no subject received antiviral or immunosuppressive therapy during the 3-year follow-up period, the authors still have not stated whether the subjects enrolled in the present study had been treated with any antiviral therapy in the early days prior to their inclusion in the study. In other words, if some subjects enrolled in this study had received antiviral therapy prior to the study, which could have influenced the results. Therefore, it is important to further address the above-mentioned question in the context of the study. The effect of BCP double mutations on viral loads remains uncertain [1Fang Z.L. Sabin C.A. Dong B.Q. Wei S.C. Chen Q.Y. Fang K.X. et al.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.J Hepatol. 2009; 50: 273-280Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar, 4Buckwold V.E. Xu Z. Chen M. Yen T.S. Ou J.H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.J Virol. 1996; 70: 5845-5851Crossref PubMed Google Scholar, 5Chen W.N. Oon C.J. Mutations and deletions in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers.Eur J Clin Invest. 2000; 30: 787-792Crossref PubMed Scopus (23) Google Scholar]. In this study, cross-sectional analysis and longitudinal analysis have been utilized for evaluating the association of HBV core promoter double mutations (A1762T and G1764A) with viral loads, and more reliable results have been obtained by the authors [[1]Fang Z.L. Sabin C.A. Dong B.Q. Wei S.C. Chen Q.Y. Fang K.X. et al.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.J Hepatol. 2009; 50: 273-280Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar]. However, viral replication, as measured by viral loads in vivo, is influenced by the interaction of the virus with the host immune system, and this has been admitted by the authors and colleagues [[1]Fang Z.L. Sabin C.A. Dong B.Q. Wei S.C. Chen Q.Y. Fang K.X. et al.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.J Hepatol. 2009; 50: 273-280Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar] and ascertained by Chu and colleagues [[6]Chu C.J. Hussain M. Lok A.S. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.Hepatology. 2002; 36: 1408-1415Crossref PubMed Scopus (268) Google Scholar]. That is to say, when we are attempting to investigate viral loads, we should also be paying attention to the influence of the viral and host factors, such as age, sex and viral genotype, etc., on viral loads. In Table 3 [[1]Fang Z.L. Sabin C.A. Dong B.Q. Wei S.C. Chen Q.Y. Fang K.X. et al.The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.J Hepatol. 2009; 50: 273-280Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar], however, the authors have not provided any details regarding the baseline characteristics of subjects, including age, sex and viral genotype, either for the BCP double mutation subgroup or for the wild-type subgroup. Moreover, it is also unclear whether viral loads were associated with the other factors considered, including age, sex and viral genotype, either in the BCP double mutations subgroup or in the wild-type subgroup. Therefore, the aforementioned question needs to be considered and further investigated.

Effects of Mutations in the X Gene of Hepatitis B Virus on the Virus Replication

Hepatitis B Virus X Mutations Affect Clinicopathological or Histopathological Characteristics in Patients with Chronic Hepatitis B Virus Infection

The A1762T/G1764A Mutations Enhance HBV Replication by Alternating Viral Transcriptome.

Hepatitis B Virus Mutations Associated with in Situ Expression of Hepatitis B Core Antigen, Viral Load and Prognosis in Chronic Hepatitis B Patients

HBV T1719G Mutation Reduced HBV Replication Through Mutant Enh II and HBx Protein in Vitro.

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated

The Association of HBV Core Promoter Double Mutations (A1762T and G1764A) with Viral Load Differs Between HBeAg Positive and Anti-Hbe Positive Individuals: A Longitudinal Analysis

Effect of hepatitis B virus whole-X gene on HEK293 cells

Mutations in the X Gene of the Hepatitis B virus and Their Influence on Outcome CHB Infection in Three-Generations in the Family

Effect of Multiple Mutations in the Core Promoter and Pre‐core/core Region of Hepatitis B Virus Genome on the Response to Interferon in E Antigen‐positive Chronic Hepatitis B

The Clinical Significance of Nucleotide G1613A and C1653T Mutations in the Core Promoter Region of Hepatitis B Virus

Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B

Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Sequential Accumulation of the Mutations in Core Promoter of Hepatitis B Virus is Associated with the Development of Hepatocellular Carcinoma in Qidong, China.

Study on X gene mutation of hepatitis B virus from patients with hepatocellular carcinoma

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma

The Effect of Mutation of Hepatitis B Virus Core Protein Dimer Interface Domain Related to Nucleocapsid Formation on HBV Replication

[Mutations and Their Significance in the Corepromoter Region of Hepatitis B Virus].

The relationship between HBV-associated histopathological indexes, X gene mutations and prognosis in patients with chronic hepatitis B virus infection